1. Report scope & Methodology
1.1 Scope of the Report
1.2 Research Methodology
1.3 Executive Summary
2. Strategic Recommendations
2.1 Development of health information technology
2.2 Focus on improving test utilization
2.3 Program for functional structural biology research
3. Proteomics Market: Product Outlook4. Global Proteomics Market: Sizing and Forecast
4.1 Global Proteomics Market Size, By Value, Year 2016-2026
5. Global Proteomics Market Segmentation - By Component, By Application, and By End User
5.1 Competitive Scenario of Global Proteomics Market: By Component
5.1.1 Instruments - Market Size and Forecast (2016-2026)
5.1.2 Reagents - Market Size and Forecast (2016-2026)
5.1.3 Services - Market Size and Forecast (2016-2026)
5.2 Competitive Scenario of Global Proteomics Market: By Application
5.2.1 Clinical Diagnostic - Market Size and Forecast (2016-2026)
5.2.2 Drug Discovery - Market Size and Forecast (2016-2026)
5.2.3 Others - Market Size and Forecast (2016-2026)
5.3 Competitive Scenario of Global Proteomics Market: By End User
5.3.1 Hospitals - Market Size and Forecast (2016-2026)
5.3.2 Labs and Clinics - Market Size and Forecast (2016-2026)
5.3.3 Others - Market Size and Forecast (2016-2026)
6.Global Proteomics Market: Regional Analysis
6.1 Competitive Scenario of Global Proteomics Market: By Region
7. North America Proteomics Market: Segmentation (By Component, By Application, and By End User)
7.1 North America Proteomics Market: Size and Forecast (2016-2026), By Value
7.2 North America Proteomics Market - Prominent Companies
7.3 Market Segmentation By Component (Instruments, Reagents and Services)
7.4 Market Segmentation By Application (Clinical Diagnostic, Drug Discovery and Others)
7.5 Market Segmentation By End User (Hospitals, Labs and Clinics, Others)
7.6 North America Proteomics Market: Country Analysis
7.7 Market Opportunity Chart of North America Proteomics Market - By Country, By Value, 2026
7.8 Competitive Scenario of North America Proteomics Market: By Country
7.9 United States Proteomics Market: Size and Forecast (2016-2026), By Value
7.10 United States Proteomics Market Segmentation - By Component, By Application, and By End User (2016-2026)
7.11 Canada Proteomics Market: Size and Forecast (2016-2026), By Value
7.12 Canada Proteomics Market Segmentation - By Component, By Application, and By End User (2016-2026)
8. Europe Proteomics Market: Segmentation (By Component, By Application, and By End User)
8.1 Europe Proteomics Market: Size and Forecast (2016-2026), By Value
8.2 Europe Proteomics Market - Prominent Companies
8.3 Market Segmentation By Component (Instruments, Reagents and Services)
8.4 Market Segmentation By Application (Clinical Diagnostic, Drug Discovery and Others)
8.5 Market Segmentation By End User (Hospitals, Labs and Clinics, Others)
8.6 Europe Proteomics Market: Country Analysis
8.7 Market Opportunity Chart of Europe Proteomics Market - By Country, By Value, 2026
8.8 Competitive Scenario of Europe Proteomics Market: By Country
8.9 Germany Proteomics Market: Size and Forecast (2016-2026), By Value
8.10 Germany Proteomics Market Segmentation - By Component, By Application, and By End User (2016-2026)
8.11 United Kingdom Proteomics Market: Size and Forecast (2016-2026), By Value
8.12 United Kingdom Proteomics Market Segmentation - By Component, By Application, and By End User (2016-2026)
8.13 France Proteomics Market: Size and Forecast (2016-2026), By Value
8.14 France Proteomics Market Segmentation - By Component, By Application, and By End User (2016-2026)
8.15 Italy Proteomics Market: Size and Forecast (2016-2026), By Value
8.16 Italy Proteomics Market Segmentation - By Component, By Application, and By End User (2016-2026)
9. Asia Pacific Proteomics Market: Segmentation (By Component, By Application, and By End User)
9.1 Asia Pacific Proteomics Market: Size and Forecast (2016-2026), By Value
9.2 Asia Pacific Proteomics Market - Prominent Companies
9.3 Market Segmentation By Component (Instruments, Reagents and Services)
9.4 Market Segmentation By Application (Clinical Diagnostic, Drug Discovery and Others)
9.5 Market Segmentation By End User (Hospitals, Labs and Clinics, Others)
9.6 Asia Pacific Proteomics Market: Country Analysis
9.7 Market Opportunity Chart of Asia Pacific Proteomics Market - By Country, By Value, 2026
9.8 Competitive Scenario of Asia Pacific Proteomics Market: By Country
9.9 China Proteomics Market: Size and Forecast (2016-2026), By Value
9.10 China Proteomics Market Segmentation - By Component, By Application, and By End User (2016-2026)
9.11 Japan Proteomics Market: Size and Forecast (2016-2026), By Value
9.12 Japan Proteomics Market Segmentation - By Component, By Application, and By End User (2016-2026)
9.13 India Proteomics Market: Size and Forecast (2016-2026), By Value
9.14 India Proteomics Market Segmentation - By Component, By Application, and By End User (2016-2026)
9.15 South Korea Proteomics Market: Size and Forecast (2016-2026), By Value
9.16 South Korea Proteomics Market Segmentation - By Component, By Application, and By End User (2016-2026)
10. Global Proteomics Market Dynamics
10.1 Drivers
10.2 Restraints
10.3 Trends
11. Market Attractiveness
11.1 Market Attractiveness Chart of Global Proteomics Market - By Component, 2026
11.2 Market Attractiveness Chart of Global Proteomics Market - By Application, 2026
11.3 Market Attractiveness Chart of Global Proteomics Market - By End User, 2026
11.4 Market Attractiveness Chart of Global Proteomics Market - By Region, 2026
12. Competitive Landscape
12.1 Major Technological Innovations, Mergers & Acquisitions and Role of Manufacturers
12.2 Market Share Analysis
13.Company Analysis
13.1 Merck KGaA
13.2 Bio-Rad Laboratories Inc.
13.3 Thermo Fisher Scientific Inc.
13.4 Danaher
13.5 QIAGEN
13.6 Agilent Technologies
13.7 Bruker Corporation
13.8 GE Healthcare
13.9 Eurofins Scientific
13.10 Wuxi APPTECC
13.11 Promega Corporation
List of Figures
- Global Proteomics Market Size, By Value, 2016-2026 (USD Million)
- Global Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
- Global Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
- Global Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
- Global Expenses (% GDP), 2015-2019
- GDP per Capita Growth (annual %)
- World Population 65 Years & Above (% of Total), 2015-2019
- Global Proteomics Market- By Component Market Share, 2020 & 2026
- Global Proteomics Market- By Instruments, By Value (USD Million), 2016-2026
- Global Proteomics Market- By Reagents, By Value (USD Million), 2016-2026
- Global Proteomics Market- By Services, By Value (USD Million), 2016-2026
- Global Proteomics Market- By Application Market Share, 2020 & 2026
- Global Proteomics Market- By Clinical Diagnostic, By Value (USD Million), 2016-2026
- Global Proteomics Market- By Drug Discovery, By Value (USD Million), 2016-2026
- Global Proteomics Market- By Others, By Value (USD Million), 2016-2026
- Global Proteomics Market- By End User Market Share, 2020 & 2026
- Global Proteomics Market- By Hospitals, By Value (USD Million), 2016-2026
- Global Proteomics Market- By Labs and Clinics, By Value (USD Million), 2016-2026
- Global Proteomics Market- By Others, By Value (USD Million), 2016-2026
- Global Proteomics Market- By Region Market Share, 2020 & 2026
- North America Proteomics Market Size, By Value, 2016-2026 (USD Million)
- North America Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
- North America Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
- North America Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
- North America Proteomics Market- By Component, By Value (USD Million), 2016-2026
- North America Proteomics Market- By Application, By Value (USD Million), 2016-2026
- North America Proteomics Market- By End User, By Value (USD Million), 2016-2026
- Market Opportunity Chart of North America Proteomics Market- By Country, By Value (Year-2026)
- North America Proteomics Market- By Country Market Share, 2020 & 2026
- United States Proteomics Market Size, By Value, 2016-2026 (USD Million)
- United State Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
- United State Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
- United State Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
- United State Proteomics Market- By Component, By Value (USD Million), 2016-2026
- United State Proteomics Market- By Application, By Value (USD Million), 2016-2026
- United State Proteomics Market- By End User, By Value (USD Million), 2016-2026
- Canada Proteomics Market Size, By Value, 2016-2026 (USD Million)
- Canada Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
- Canada Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
- Canada Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
- Canada Proteomics Market- By Component, By Value (USD Million), 2016-2026
- Canada Proteomics Market- By Application, By Value (USD Million), 2016-2026
- Canada Proteomics Market- By End User, By Value (USD Million), 2016-2026
- Europe Proteomics Market Size, By Value, 2016-2026 (USD Million)
- Europe Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
- Europe Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
- Europe Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
- Europe Proteomics Market- By Component, By Value (USD Million), 2016-2026
- Europe Proteomics Market- By Application, By Value (USD Million), 2016-2026
- Europe Proteomics Market- By End User, By Value (USD Million), 2016-2026
- Market Opportunity Chart of Europe Proteomics Market- By Country, By Value (Year-2026)
- Europe Proteomics Market- By Country Market Share, 2020 & 2026
- Germany Proteomics Market Size, By Value, 2016-2026 (USD Million)
- Germany Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
- Germany Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
- Germany Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
- Germany Proteomics Market- By Component, By Value (USD Million), 2016-2026
- Germany Proteomics Market- By Application, By Value (USD Million), 2016-2026
- Germany Proteomics Market- By End User, By Value (USD Million), 2016-2026
- United Kingdom Proteomics Market Size, By Value, 2016-2026 (USD Million)
- United Kingdom Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
- United Kingdom Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
- United Kingdom Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
- United Kingdom Proteomics Market- By Component, By Value (USD Million), 2016-2026
- United Kingdom Proteomics Market- By Application, By Value (USD Million), 2016-2026
- United Kingdom Proteomics Market- By End User, By Value (USD Million), 2016-2026
- France Proteomics Market Size, By Value, 2016-2026 (USD Million)
- France Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
- France Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
- France Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
- France Proteomics Market- By Component, By Value (USD Million), 2016-2026
- Proteomics Market- By Application, By Value (USD Million), 2016-2026
- France Proteomics Market- By End User, By Value (USD Million), 2016-2026
- Italy Proteomics Market Size, By Value, 2016-2026 (USD Million)
- Italy Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
- Italy Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
- Italy Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
- Italy Proteomics Market- By Component, By Value (USD Million), 2016-2026
- Italy Proteomics Market- By Application, By Value (USD Million), 2016-2026
- Italy Proteomics Market- By End User, By Value (USD Million), 2016-2026
- Asia Pacific Proteomics Market Size, By Value, 2016-2026 (USD Million)
- Asia Pacific Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
- Asia Pacific Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
- Asia Pacific Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
- Asia Pacific Proteomics Market- By Component, By Value (USD Million), 2016-2026
- Asia Pacific Proteomics Market- By Application, By Value (USD Million), 2016-2026
- Asia Pacific Proteomics Market- By End User, By Value (USD Million), 2016-2026
- Market Opportunity Chart of APAC Proteomics Market- By Country, By Value (Year-2026)
- APAC Proteomics Market- By Country Market Share, 2020 & 2026
- China Proteomics Market Size, By Value, 2016-2026 (USD Million)
- China Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
- China Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
- China Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
- China Proteomics Market- By Component, By Value (USD Million), 2016-2026
- China Proteomics Market- By Application, By Value (USD Million), 2016-2026
- China Proteomics Market- By End User, By Value (USD Million), 2016-2026
- Japan Proteomics Market Size, By Value, 2016-2026 (USD Million)
- Japan Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
- Japan Current Healthcare Expenditure as percentage of GDP, 2015-2018 (In %)
- Japan Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
- Japan Proteomics Market- By Component, By Value (USD Million), 2016-2026
- Japan Proteomics Market- By Application, By Value (USD Million), 2016-2026
- Japan Proteomics Market- By End User, By Value (USD Million), 2016-2026
- India Proteomics Market Size, By Value, 2016-2026 (USD Million)
- India Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
- India Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
- India Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
- India Proteomics Market- By Component, By Value (USD Million), 2016-2026
- India Proteomics Market- By Application, By Value (USD Million), 2016-2026
- India Proteomics Market- By End User, By Value (USD Million), 2016-2026
- India Proteomics Market Size, By Value, 2016-2026 (USD Million)
- South Korea Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
- South Korea Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
- South Korea Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
- South Korea Proteomics Market- By Component, By Value (USD Million), 2016-2026
- South Korea Proteomics Market- By Application, By Value (USD Million), 2016-2026
- South Korea Proteomics Market- By End User, By Value (USD Million), 2016-2026
- Market Attractiveness Chart of Global Proteomics Market- By Component (Year-2026)
- Market Attractiveness Chart of Global Proteomics Market- By Application (Year-2026)
- Market Attractiveness Chart of Global Proteomics Market- By End User (Year-2026)
- Market Attractiveness Chart of Global Proteomics Market- By Region (Year-2026)
- Global Proteomics company market share (%), 2020
- Merck KGaA Sales Revenues, 2016-2020 (USD Million)
- Merck KGaA Gross Profit, 2016-2020 (USD Million)
- Merck KGaA Plc Sales Revenue Split, By Business Segment (%), FY2020
- Merck KGaA Plc Sales Revenue Split, By Geography Segment (%), FY2020
- Bio-Rad Laboratories Inc. Sales Revenues, 2015-2019 (USD Million)
- Bio-Rad Laboratories Inc. Net Income, 2015-2019 (USD Million)
- Bio-Rad Laboratories Inc. sales Revenues, By Business Segment (%), FY2019
- Bio-Rad Laboratories Inc. sales Revenue, By Geographical Segment (%), FY2019
- Thermo Fisher Scientific Inc. Sales Revenues, 2016-2020 (USD Million)
- Thermo Fisher Scientific Inc. Net Income, 2016-2020 (USD Million)
- Thermo Fisher Scientific Inc. sales Revenues, By Business Segment (%), FY2020
- Thermo Fisher Scientific Inc. sales Revenue, By Geographical Segment (%), FY2020
- Danaher Sales Revenues, 2016-2020 (USD Million)
- Danaher Gross Profit, 2016-2020 (USD Million)
- Danaher sales Revenues, By Business Segment (%), FY2020
- Danaher sales Revenue, By Geographical Segment (%), FY2020
- QIAGEN Sales Revenues, 2016-2020 (USD Million)
- QIAGEN Gross Profit, 2016-2020 (USD Million)
- QIAGEN sales Revenues, By Business Segment (%), FY2020
- QIAGEN sales Revenue, By Geographical Segment (%), FY2020
- Agilent Technologies Sales Revenues, 2016-2020 (USD Million)
- Agilent Technologies Net Income, 2016-2020 (USD Million)
- Agilent Technologies sales Revenues, By Business Segment (%), FY2020
- Agilent Technologies sales Revenue, By Geographical Segment (%), FY2020
- Bruker Corporation Sales Revenues, 2016-2020 (USD Million)
- Bruker Corporation Gross Profit, 2016-2020 (USD Million)
- Bruker Corporation sales Revenues, By Business Segment (%), FY2020
- Bruker Corporation sales Revenue, By Geographical Segment (%), FY2020
- GE Healthcare Sales Revenues, 2016-2020 (USD Million)
- GE Healthcare sales Revenues, By Business Segment (%), FY2020
- GE Healthcare sales Revenue, By Geographical Segment (%), FY2020
- Eurofins Scientific Sales Revenues, 2016-2020 (USD Million)
- Eurofins Scientific sales Revenue, By Geographical Segment (%), FY2020
- Wuxi APPTECC Revenue, 2015-2019 (In USD Million)
- Wuxi APPTECC Net Sales, By Operating Segment, 2019 (In %)